• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Ironwood Pharmaceuticals

Anonymous board for Ironwood Pharmaceuticals
Replies
13
Views
6K
anonymous
Replies
1
Views
2K
anonymous
Replies
7
Views
4K
anonymous
Replies
5
Views
2K
anonymous
Replies
15
Views
5K
anonymous
Replies
0
Views
2K
anonymous
Replies
10
Views
3K
anonymous
Replies
123
Views
58K
anonymous
Replies
9
Views
4K
anonymous
Replies
53
Views
11K
anonymous
Replies
4
Views
3K
anonymous
Replies
4
Views
2K
anonymous
CEO
Replies
2
Views
3K
anonymous
Replies
70
Views
19K
anonymous
Replies
3
Views
2K
anonymous
Replies
12
Views
4K
anonymous
Replies
1
Views
2K
anonymous
Replies
28
Views
6K
anonymous
Replies
0
Views
1K
anonymous
Replies
5
Views
3K
anonymous